IRA’s $2,000 out-of-pocket cap helps few; most won’t hit the threshold Insurers raise deductibles, replace flat co-pays with ...

CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

WASHINGTON — Trump administration officials are expected to release more details on their plan to lower prescription drug ...

In other countries, the government negotiates with pharmaceutical companies directly to set a single market price. In the U.S ...

An executive order by President Trump that threatens pharmaceutical companies with targeted retaliation and lawsuits if they fail to lower drug prices raises serious legal questions and could create ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

The Inflation Reduction Act includes an exemption for orphan drugs for a single indication, but experts say this is far from ...

Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...

Donald Trump Jr. agrees with Mark Cuban on social media over the problem of drug middlemen in American health care.

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

The Trump administration recently released an executive order directing Medicare and Medicaid drug reimbursement to be based ...

The president promised lower prices on medications for Americans, but the state’s independent pharmacies doubt that will ...